Kazia Therapeutics Moves Forward with Clinical Trials for Paxalisib Targeting Rare Epilepsy Disorders #Australia #Sydney #Kazia_Therapeutics #Paxalisib #Sovargen_Co.
@newsen.bsky.social
@newsen.bsky.socialKazia Therapeutics Moves Forward with Clinical Trials for Paxalisib Targeting Rare Epilepsy Disorders #Australia #Sydney #Kazia_Therapeutics #Paxalisib #Sovargen_Co.
@newsen.bsky.socialKazia Therapeutics Takes Significant Step in Pediatric Brain Cancer Research with First Patient Dosed in PNOC035 Study #USA #pediatric_cancer #Sydney #Kazia_Therapeutics #Paxalisib